Wellbutrin and Bone neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Bone neoplasm malignant is reported as a side effect among people who take Wellbutrin (bupropion hydrochloride), especially for people who are female, 40-49 old, also take Zometa, and have Osteoporosis.

The phase IV clinical study analyzes which people have Bone neoplasm malignant when taking Wellbutrin. It is created by eHealthMe based on reports of 101,581 people who have side effects when taking Wellbutrin from the FDA, and is updated regularly.

What is Wellbutrin?

Wellbutrin has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 117,107 Wellbutrin users. Check the latest studies of Wellbutrin.

What is Bone neoplasm malignant?

Bone neoplasm malignant (cancer of bone) is found to be associated with 294 drugs and 214 conditions by eHealthMe. Check the latest studies of Bone neoplasm malignant.

On Jul, 09, 2026

101,581 people reported to have side effects when taking Wellbutrin.
Among them, 47 people (0.05%) have Bone neoplasm malignant.

Could Wellbutrin cause Bone neoplasm malignant?

Among these 47 people:

What is the gender of people who have Bone neoplasm malignant when taking Wellbutrin? *

female: 61.7 %
male: 38.3 %

What is the age of people who have Bone neoplasm malignant when taking Wellbutrin? *

What are other drugs people take besides Wellbutrin? *

What are other side effects people have besides Bone neoplasm malignant? *

Pain: 39 people, 82.98%
Bone Disorder: 33 people, 70.21%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 29 people, 61.70%
Osteonecrosis Of Jaw (death of bone of jaw): 28 people, 59.57%
Rashes (redness): 28 people, 59.57%
Rib Fracture: 28 people, 59.57%
Back Pain: 27 people, 57.45%
Osteitis (a general term for inflammation of bone): 27 people, 57.45%
Fever: 26 people, 55.32%
Anaemia (lack of blood): 26 people, 55.32%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 22 people, 46.81%
Sleep Disorder: 9 people, 19.15%
Neoplasm Malignant (cancer tumour): 9 people, 19.15%
Metastases To Bone (cancer spreads to bone): 9 people, 19.15%
Breast Cancer Metastatic: 8 people, 17.02%
Inflammation: 4 people, 8.51%
Arrhythmia Supraventricular (irregular heartbeat supraventricular origin): 4 people, 8.51%
High Blood Pressure: 1 person, 2.13%
High Blood Cholesterol: 1 person, 2.13%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Wellbutrin and have Bone neoplasm malignant?

- Check whether Bone neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Wellbutrin:

Wellbutrin (117,107 reports)

Browse all side effects of Wellbutrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone neoplasm malignant:

Bone neoplasm malignant (294 drugs)

Browse all the conditions that are associated with Bone neoplasm malignant:

Bone neoplasm malignant (214 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bupropion hydrochloride (the active ingredients of Wellbutrin) and Wellbutrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.